Literature DB >> 20557982

Synthesis and evaluation of quinazolinone derivatives as inhibitors of NF-kappaB, AP-1 mediated transcription and eIF-4E mediated translational activation: inhibitors of multi-pathways involve in cancer.

Rajan S Giri1, Hardik M Thaker, Tony Giordano, Bing Chen, Sam Nuthalapaty, Kamala K Vasu, Vasudevan Sudarsanam.   

Abstract

In our effort to discover and develop small molecule multi-pathway inhibitors which may be useful as tools for treating cancerous conditions, we have synthesized a small library of 2-thiazole-5-yl-3H-quinazolin-4-one derivatives. Synthesized compounds were evaluated as inhibitors of NF-kappaB and AP-1 mediated transcriptional and eIF-4E mediated translational activation as these transcription and translation factors are known to play a pivotal role in initiation and progression of cancer. The results from the study suggest the utility of the 2-thiazole-5-yl-3H-quinazolin-4-one scaffold as a promising scaffold for the design of novel multi-pathway inhibitors, which can be explored as anti-cancer agents. 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20557982     DOI: 10.1016/j.ejmech.2010.04.038

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

1.  Synthesis, molecular docking, and cytotoxicity of quinazolinone and dihydroquinazolinone derivatives as cytotoxic agents.

Authors:  Fahimeh Taayoshi; Aida Iraji; Ali Moazzam; Meysam Soleimani; Mehdi Asadi; Keyvan Pedrood; Mosayeb Akbari; Hafezeh Salehabadi; Bagher Larijani; Neda Adibpour; Mohammad Mahdavi
Journal:  BMC Chem       Date:  2022-05-18

2.  MJ-66 induces malignant glioma cells G2/M phase arrest and mitotic catastrophe through regulation of cyclin B1/Cdk1 complex.

Authors:  Wei-Ting Liu; Ching Chen; I-Chen Lu; Sheng-Chu Kuo; Kuo-Hsiung Lee; Tai-Lin Chen; Ta-Shu Song; Yi-Liang Lu; Po-Wu Gean; Mann-Jen Hour
Journal:  Neuropharmacology       Date:  2014-08-05       Impact factor: 5.250

Review 3.  The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas.

Authors:  Ines Garces de Los Fayos Alonso; Huan-Chang Liang; Suzanne D Turner; Sabine Lagger; Olaf Merkel; Lukas Kenner
Journal:  Cancers (Basel)       Date:  2018-03-28       Impact factor: 6.639

4.  Small molecule inhibitors targeting activator protein 1 (AP-1).

Authors:  Na Ye; Ye Ding; Christopher Wild; Qiang Shen; Jia Zhou
Journal:  J Med Chem       Date:  2014-05-27       Impact factor: 8.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.